Curran Simpson

Track

Insider profile

Currently holds a position at Regenxbio Inc

Positions

Position Company Period
Senior Vice President - Product Development, Chief Technology Officer Regenxbio Inc Aug. 1, 2018 -
Senior Vice President - Technical Operations Regenxbio Inc Aug. 1, 2015 - Aug. 1, 2018
Senior Vice President - Operations Human Genome Sciences Inc Dec. 1, 2005 - July 30, 2012
Curran Simpson's trades of Regenxbio Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-10-10 2025-10-09
US Regenxbio Inc (RGNX)
PlS Planned sale
31,928 +23.5%
367.28
US$4,285,325 		31,928 +23.5% 367.28 US$4,285,325
2025-10-09 2025-10-09
US Regenxbio Inc (RGNX)
PrS Proposed sale
30,905
349.80
US$1,211,274 		30,905 349.80 US$1,211,274
2025-10-01 2025-09-29
US Regenxbio Inc (RGNX)
PlS Planned sale
85,584 -11.7%
318.45
US$1,488,487 		85,584 -11.7% 318.45 US$1,488,487
2025-09-12 2025-09-10
US Regenxbio Inc (RGNX)
PlS Planned sale
7,734 -3.1%
10.02
US$77,495 		7,734 -3.1% 10.02 US$77,495
2025-09-10 2025-09-10
US Regenxbio Inc (RGNX)
PrS Proposed sale
15,358
9.89
US$151,891 		15,358 9.89 US$151,891
2024-08-05 2024-08-01
US Regenxbio Inc (RGNX)
PlS Planned sale
100 -0.1%
15.00
US$1,500 		100 -0.1% 15.00 US$1,500
2024-07-30 2024-07-29
US Regenxbio Inc (RGNX)
PlS Planned sale
9,648 -5.4%
15.04
US$145,106 		9,648 -5.4% 15.04 US$145,106
2024-07-29 2024-07-29
US Regenxbio Inc (RGNX)
PrS Proposed sale
25,106
14.33
US$359,769 		25,106 14.33 US$359,769
2021-01-14 2021-01-14
US Regenxbio Inc (RGNX)
PlS Planned sale
11,612 -39.6%
50.01
US$580,716 		11,612 -39.6% 50.01 US$580,716
2021-01-14 2021-01-12
US Regenxbio Inc (RGNX)
PlS Planned sale
1,700 -8.7%
50.03
US$85,051 		1,700 -8.7% 50.03 US$85,051
2021-01-11 2021-01-07
US Regenxbio Inc (RGNX)
PlS Planned sale
5,185 -22.6%
50.01
US$259,302 		5,185 -22.6% 50.01 US$259,302
2020-02-12 2020-02-11
US Regenxbio Inc (RGNX)
PlS Planned sale
3,692 -48.3%
51.37
US$189,658 		3,692 -48.3% 51.37 US$189,658
2020-02-12 2020-02-11
US Regenxbio Inc (RGNX)
PlS Planned sale
8,872 -53.7%
50.13
US$444,753 		8,872 -53.7% 50.13 US$444,753
2020-02-12 2020-02-10
US Regenxbio Inc (RGNX)
PlS Planned sale
44,429 -81.8%
50.22
US$2,231,224 		44,429 -81.8% 50.22 US$2,231,224
2020-02-07 2020-02-05
US Regenxbio Inc (RGNX)
PlS Planned sale
5,637 -19.9%
50.00
US$281,850 		5,637 -19.9% 50.00 US$281,850
2020-01-21 2020-01-17
US Regenxbio Inc (RGNX)
PlS Planned sale
5,922 -20.4%
50.00
US$296,100 		5,922 -20.4% 50.00 US$296,100
2019-05-30 2019-05-28
US Regenxbio Inc (RGNX)
PlS Planned sale
18,000 -31.3%
50.00
US$900,000 		18,000 -31.3% 50.00 US$900,000
2019-02-27 2019-02-25
US Regenxbio Inc (RGNX)
PlS Planned sale
5,300 -11.8%
54.05
US$286,465 		5,300 -11.8% 54.05 US$286,465
2019-02-07 2019-02-05
US Regenxbio Inc (RGNX)
PlS Planned sale
43,832 -52.6%
50.08
US$2,195,107 		43,832 -52.6% 50.08 US$2,195,107